Cambridge Cognition Holdings PLC (LON:COG) had its Corporate rating reiterated by FinnCap

Analyst Ratings For Cambridge Cognition Holdings PLC (LON:COG)

Story continues below

Today, FinnCap reiterated its Corporate rating on Cambridge Cognition Holdings PLC (LON:COG).

There are 0 Strong Buy Ratings, no Sell Ratings, no Hold Ratings, no Buy Ratings on the stock.

The current consensus rating on Cambridge Cognition Holdings PLC (LON:COG) is N/A with a consensus target price of GBX 175 per share, a potential .

Some recent analyst ratings include

  • 12/19/2018-Cambridge Cognition Holdings PLC (LON:COG) had its Corporate rating reiterated by FinnCap
  • 3/31/2017-Cambridge Cognition Holdings PLC (LON:COG) has coverage initiated with a Buy rating

    About Cambridge Cognition Holdings PLC (LON:COG)
    Cambridge Cognition Holdings Plc, a neuroscience digital health company, specializes in the precise measurement of clinical outcomes in neurological disorders worldwide. The company operates through three segments: Pharmaceutical Clinical Trials, Academic Research, and Healthcare Technology. It delivers near-patient assessment solutions to enhance the understanding, diagnosis, and treatment in brain health. The company provides Cantab Connect Research, a cognitive assessment system for researchers to measure cognitive function; CANTAB Occupational Health, an assessment system that measures mental health in the workplace; and Cognitive health and wellbeing solutions, which optimizes mental wellbeing and performance throughout life. It also offers CANTAB Mobile, a sensitive screening tool for healthcare professionals to identify the earliest signs of clinically relevant memory impairment indicative of Alzheimer's disease; and CANTAB Insight, an analytical assessment tool that measures brain function and cognitive health across various domains. In addition, the company provides CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease. Its customers also include contract research organizations, academic research institutions, and healthcare providers in brain and mental health related disciplines. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

    Recent Trading Activity for Cambridge Cognition Holdings PLC (LON:COG)
    Shares of Cambridge Cognition Holdings PLC closed the previous trading session at 84.00 −16.50 16.42% with 22.39 shares trading hands.

    An ad to help with our costs